274 related articles for article (PubMed ID: 22567190)
1. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.
Torres AG; Threlfall RN; Gait MJ
Artif DNA PNA XNA; 2011; 2(3):71-8. PubMed ID: 22567190
[TBL] [Abstract][Full Text] [Related]
2. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.
Fabani MM; Gait MJ
RNA; 2008 Feb; 14(2):336-46. PubMed ID: 18073344
[TBL] [Abstract][Full Text] [Related]
3. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection.
Torres AG; Fabani MM; Vigorito E; Gait MJ
RNA; 2011 May; 17(5):933-43. PubMed ID: 21441346
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
[TBL] [Abstract][Full Text] [Related]
6. Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs.
Torres AG; Fabani MM; Vigorito E; Williams D; Al-Obaidi N; Wojciechowski F; Hudson RH; Seitz O; Gait MJ
Nucleic Acids Res; 2012 Mar; 40(5):2152-67. PubMed ID: 22070883
[TBL] [Abstract][Full Text] [Related]
7. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
8. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs).
Nulf CJ; Corey D
Nucleic Acids Res; 2004; 32(13):3792-8. PubMed ID: 15263060
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
[TBL] [Abstract][Full Text] [Related]
10. A direct comparison of anti-microRNA oligonucleotide potency.
Lennox KA; Behlke MA
Pharm Res; 2010 Sep; 27(9):1788-99. PubMed ID: 20424893
[TBL] [Abstract][Full Text] [Related]
11. 2'-
Honcharenko D; Rocha CSJ; Lundin KE; Maity J; Milton S; Tedebark U; Murtola M; Honcharenko M; Slaitas A; Smith CIE; Zain R; Strömberg R
Nucleic Acid Ther; 2022 Jun; 32(3):221-233. PubMed ID: 35238623
[TBL] [Abstract][Full Text] [Related]
12. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.
Oh SY; Ju Y; Park H
Mol Cells; 2009 Oct; 28(4):341-5. PubMed ID: 19812898
[TBL] [Abstract][Full Text] [Related]
13. Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene Silencing.
Debacker AJ; Sharma VK; Meda Krishnamurthy P; O'Reilly D; Greenhill R; Watts JK
Biochemistry; 2019 Feb; 58(6):582-589. PubMed ID: 30520300
[TBL] [Abstract][Full Text] [Related]
14. Gymnotic Delivery of LNA Mixmers Targeting Viral SREs Induces HIV-1 mRNA Degradation.
Hillebrand F; Ostermann PN; Müller L; Degrandi D; Erkelenz S; Widera M; Pfeffer K; Schaal H
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832397
[TBL] [Abstract][Full Text] [Related]
15. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
Liu Y; Braasch DA; Nulf CJ; Corey DR
Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
Turner JJ; Arzumanov AA; Gait MJ
Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
[TBL] [Abstract][Full Text] [Related]
17. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent.
Oh SY; Ju Y; Kim S; Park H
Oligonucleotides; 2010 Oct; 20(5):225-30. PubMed ID: 20946011
[TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.
Chen S; Le BT; Chakravarthy M; Kosbar TR; Veedu RN
Sci Rep; 2019 Apr; 9(1):6078. PubMed ID: 30988454
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of crosslinked 2'-OMe RNA duplexes and their application for effective inhibition of miRNA function.
Abdelhady AM; Hirano Y; Onizuka K; Okamura H; Komatsu Y; Nagatsugi F
Bioorg Med Chem Lett; 2021 Sep; 48():128257. PubMed ID: 34246752
[TBL] [Abstract][Full Text] [Related]
20. Cellular delivery and antisense effects of peptide nucleic acid conjugated to polyethyleneimine via disulfide linkers.
Berthold PR; Shiraishi T; Nielsen PE
Bioconjug Chem; 2010 Oct; 21(10):1933-8. PubMed ID: 20873710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
